Risk factor
Negligible price volatility
Profitability factor
Good growth
About
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of SNN is 38 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sugg
Buy
Sell